BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chisthi MM. Current research status and future directions of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(3): 99068 [PMID: 40092943 DOI: 10.4251/wjgo.v17.i3.99068]
URL: https://www.wjgnet.com/1948-5204/full/v17/i3/99068.htm
Number Citing Articles
1
Zizhuo Wang, Wei Xu, Songlin Song, Yanqiao Ren, Jiacheng Liu, Yiming Liu, Xuefeng Kan, Chuansheng Zheng, Bin Liang. Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort StudyCancers 2026; 18(2): 314 doi: 10.3390/cancers18020314
2
Li Gao, Hong Wu, Sheng-Yuan Du, Zi-Li Lv. Therapeutic potential of CDK8 inhibitor combined with sorafenib for hepatocellular carcinoma: mechanistic insights and in vitro validationEuropean Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-025-03780-0
3
Yili Qu, Haizhi Xu, Xianjun Guo, Chunyan Zhang, Bei Xu. Effectiveness of a nurse-led pain management model following TACE: a retrospective analysisScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-09399-9